HIGHFDA DEVICE

Percussionaire IPV In-Line Valve Recall Aims to Stop Use Over Leakage Risk in Ventilators

Percussionaire recalled 59,160 Phasitron 5 IPV In-Line Valve sets worldwide after an IFU update flagged a pressure-relief leak when used with ventilators. The defect endangers neonates and infants and patients under 10 kg with tidal volumes under 50 mL. Healthcare providers should halt use immediately.

Official notice
PercussionaireHealth & Personal CareMedical DevicesP5-TEE-20P5-TEEUDI-DI: 00849436000723

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
September 17, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 17, 2025
Hazard Level
HIGH
Brand
Percussionaire
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
INFANTS, PREGNANT, GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Percussionaire
Product type
IPV In-Line Valve (Intrapulmonary Percussive Ventilation)
Model numbers
P5-TEE-20, P5-TEE, UDI-DI: 00849436000723, 240326, 250116, 240418, 250324, 240610 +13 more
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 17, 2025

  2. Reported by FDA DEVICE

    October 22, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

IFU update; in-line valve, with pressure relief seal may leak when used with ventilator; don't use in neonates/infants, with target tidal volumes less-than50mL or less-than10kg- at high risk of cardiopulmonary/neurological compromise due to unrecognized hypoventilation, updates for continued use in others before design update; leak may cause respiratory acidosis, hypoxemia, or respiratory failure.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Percussionaire Corporation or your healthcare provider for instructions. Notification method: Letter

About This Product

The Phasitron 5 IPV In-Line Valve is used in intrapulmonary percussive ventilation systems. It is integrated into medical devices used by patients needing respiratory support.

Why This Is Dangerous

A leaked valve during ventilation can cause inadequate ventilation leading to respiratory acidosis, low oxygen levels, and potential respiratory failure.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

The recall affects patients and healthcare providers worldwide who rely on this component for ventilation. Immediate action could prevent serious complications and potential life-threatening outcomes.

Practical Guidance

How to identify if yours is affected

  1. Identify models P5-TEE-20 and P5-TEE and cross-check UDI-DI 00849436000723.
  2. Consult your hospital's biomedical engineering department for verification.

Where to find product info

Use the FDA recall page linked in enforcement reports for official identifiers and instructions.

What timeline to expect

Recall remedy is via manufacturer instructions and notification by letter. Specific replacement or refund timing is not provided.

If the manufacturer is unresponsive

  • Escalate to hospital risk management or regulatory authority.
  • Document all communications with the manufacturer.

How to prevent similar issues

  • In future, verify device recalls through FDA and manufacturer updates prior to implant or use.
  • Maintain updated IFUs and ensure staff are trained on gear changes.
  • Ensure strict ventilator compatibility checks with inline valves.

Documentation advice

Keep copy of recall letter, authenticate device IDs, photograph labels, record communications with manufacturers and clinicians.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers include P5-TEE-20 and P5-TEE. UDI-DI 00849436000723. Additional model codes: 240326, 250116, 240418, 250324, 240610, 250616, 240620, 241121, 230612, 240826, WO04884, 241118, WO06020, 241203, WO05019, 250111, WO04827, WO04756. Worldwide distribution with US nationwide and other countries listed in the recall.

Reported Incidents

No specific incident counts are provided in the source document.

Key Facts

  • IFU update as root cause
  • Leak potential with ventilators
  • Hazardous for neonates/infants or <10 kg or <50 mL tidal volumes
  • Class I recall
  • Worldwide distribution including US, Russia, Japan, Switzerland, Canada, Qatar, Chile, South Africa,

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
INFANTSPREGNANTGENERALPETS
Injury Types
CHOKINGLACERATIONELECTRICALFALLSUFFOCATIONCRUSHINGOTHER

Product Classification

Product Details

Model Numbers
P5-TEE-20
P5-TEE
UDI-DI: 00849436000723
240326
250116
+16 more
Affected States
ALL
Report Date
October 22, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more